|
Kehan Xu is a cross-asset/multi-strategy investor. Kehan received his PhD in strategy from Mays Business School at Texas A&M University and his MBA in investments from the University of Miami. He has published articles in leading academic journals, such as Journal of the Academy of Marketing Science, Journal of Small Business Management, Journal of Management Accounting Research, Journal of Management, and Academy of Management Perspectives. Moreover, he has presented his empirical findings at American Marketing Association annual conferences (2019-2025). Dr. Xu has also co-founded a biopharma venture (2016-2024) and designed/licensed quantitative long/short global equity trading strategies for a major family office (2020-2023).
|